Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
iPSC-Derived NK Cells and the Future of Immunotherapy
By Christine Filippis / February 14, 2025
Induced pluripotent stem cell (iPSC)-derived NK cells are revolutionising cancer immunotherapy by offering a scalable and reliable source of immune...
Read More
Cartherics presents at Australia and New Zealand’s Biologics Festival
By Christine Filippis / February 7, 2025
Cartherics’ Chief Operating Officer, Dr. Ian Nisbet recently presented at the 3rd ANZ Biologics Festival at Crown Promenade in Melbourne....
Read More
The Power and Potential of Natural Killer Cell Therapies: A New Awakening
By Christine Filippis / December 20, 2024
In a recent article published in CGTLive, Cartherics’ Prof. Alan Trounson, Karl Trounson, Dr Walid Azar and Prof. Richard Boyd,...
Read More
